We are proud to count some of the world’s most forward-looking and experienced minds in science, public engagement, technology, engineering and education amongst our board members.
Dr Christopher J. Horn (Chairman)
Dr Christopher J. Horn is former CEO and co-founder of IONA Technologies. He was the initial developer of Orbix® and held the joint offices of IONA’s president, chief executive officer and chairman of the board from IONA’s inception until May 2000. He served as the chairman of the board of IONA from May 2000 to May 2003 when he re-assumed the CEO position, a post he held until his appointment to vice-chairman in April 2005. Dr Horn has been a non-executive director of a number of privately held software companies and business associations and advisor to a number of venture capital firms. Dr Horn is currently the Chair of Gridstore, a storage grid company based in Mountain View, and of Sophia, which is "making content shoppable". He also became the Chairman of the Northern Ireland Science Park Connect Initiative in Belfast. He is an occasional opinion writer for the Irish Times.
CLARE MATTERSON, CBEFormer Director of Strategy & current Special Advisor, Wellcome Trust
Clare Matterson CBE is the former Director of Strategy at Wellcome Trust, she led on strategy, policy, advocacy and education, communicating the work of the Trust, leading grant management and incubating new initiatives.
Clare received a CBE in recognition of her services to public engagement with Science. From 2004 to 2014, Clare was Director of Culture & Society at the Wellcome Trust. With a small team, she conceived and led the first 10 years of Wellcome Collection - the Trust's highly acclaimed public venue. She was responsible for bringing the arts and humanities into the core of the Trust's work and for extending its activities to engage the public with science. Passionate about education, Clare led the Wellcome Trust's initiative to create the National Science Learning Centre – a partnership with the UK Government to drive improvement in science education. She is currently Chair of the National Forum for Public Engagement with STEM.
DAVID MARTINDirector of Geo Data Operations, Google
David Martin is Director of Geo Data Operations with Google. Previously he was Google's Director of EMEA Finance and Business Intelligence. Prior to joining Google in 2005, David was Head of Strategic Planning for eircom (now eir). He worked for several years as a Management Consultant with McKinsey & Co. before which he was Business Development Manager for an opto-electronics start-up based in Dublin. David started his career as an Electronic Engineer working with the Toshiba Corporation both in the USA as an Advanced Market Development Engineer and also for five years as a Laser Application Engineer based in Tokyo, Japan.
Deborah BullAssistant Principal (Culture & Engagement), King’s College London
Deborah Bull has enjoyed a thirty year career in the arts as a dancer with The Royal Ballet, as the author of four books, as Creative Director of the Royal Opera House and, since 1998, as presenter and writer of a wide range of programmes across both television and radio. In 2012 she joined King's College London to provide leadership and direction to its wide range of collaborations with the cultural sector. As Assistant Principal (Culture & Engagement), King's College London, Deborah provides leadership across the university to extend and enrich its collaborative activities with the cultural sector; and leads on development of the university's external engagement profile within London, maximising the potential of King’s location in the heart of the city. She has established culture as integral to the delivery of the university's ambitions and is leading on the development of Science Gallery London. In 1998 she was awarded a CBE for her contribution to the arts. She has served on Arts Council England, as a Governor of the BBC, as a judge for the 2010 Booker Prize and is currently a member of the governing body of the Arts and Humanities Research Council, and Vice President for Cultural Development on the Council for the British Science Association.
DR JOHN CLIMAXFounder of ICON Clinical Research plc
John Climax, Ph.D. is a co-founder of ICON Clinical Research plc. He has over 25 years of experience in the clinical research industry globally. Dr Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his Ph.D. in clinical pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations. Dr Climax is an adjunct Professor at the Royal College of Surgeons, Ireland and Chairman of the Human Dignity Foundation, a Swiss based charity, as well as serving on the Board of some biotech companies. Dr Climax has previously held the positions of CEO and subsequently Executive Chairman of ICON plc. Since January 2010, Dr Climax serves on the ICON plc board as Chairman Emeritus. During 2010, Dr Climax founded DS Biopharma, a life sciences company focusing bioactive lipids. Dr. Climax is a named inventor on a number of patents.
Dr Patrick PrendergastProvost, Trinity College Dublin
Patrick Prendergast took office as the 44th Provost of Trinity College Dublin on 1 August 2011. Dr Prendergast first came to Trinity in 1983 graduating with a degree in Mechanical Engineering, and later with a Ph.D. in bioengineering. After post-doctoral positions in Bologna, Italy and Nijmegen, The Netherlands, Dr Prendergast returned as a Lecturer to Trinity in 1995, and was elected a Fellow of the College in 1998. Together with colleagues in Engineering, Dentistry, Medicine, and Physiology he established the Trinity Centre for Bioengineering in 2002, was elected a Member of the Royal Irish Academy in 2008, and awarded an ScD in 2009. He served as Dean of Graduate Studies 2004–2007 and was the first appointment to the expanded position of Vice-Provost as Chief Academic Officer in 2008. Dr Prendergast’s research is in the area of medical device technologies, where he has developed well-known theories on mechanoregulation of tissue phenotype. He has significant industrial collaboration in implant design and development, including in his role as a board member of Clearstream Technologies Group plc. Dr Prendergast was elected as Provost of Trinity by academic staff and students on a manifesto of asserting Trinity’s global presence as Ireland’s premier university. His term of office is for ten years from 2011 to 2021.
PROF JOHN J. BOLANDVice-President and Dean of Research, Trinity College Dublin
Prof. John J. Boland received a BSc degree in chemistry from University College Dublin and a PhD in chemical physics from the California Institute of Technology, where he was an IBM graduate fellow and recipient of the Newby-McKoy graduate research award. From 1984 to 1994 Prof. Boland was a member of the research staff at the IBM T.J. Watson Research Center (New York). In 1994 he joined the chemistry faculty at the University of North Carolina at Chapel Hill where he was appointed the J.J. Hermans Chair Professor of Chemistry and Applied and Materials Science. In 2002 Prof. Boland moved to the School of Chemistry at Trinity College Dublin as a Science Foundation Ireland Principal Investigator. In 2004 he was appointed Director of the Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN). He was elected a Fellow of Trinity College in 2008, a fellow of the American Vacuum Society (AVS) in 2009 and a fellow of the American Association for the Advancement of Science (AAAS) in 2010. He was Laureate of the 11th ACSIN Nanoscience Prize in 2011, St Petersburg, Russia and recipient of the Science Foundation Ireland (SFI) Research Image of the year in 2011. Prof. Boland was awarded a €2.5 million research grant by the European Research Council (ERC) in 2013, the second only Advanced ERC grant ever awarded in Physical Sciences in Ireland. The award will allow him to continue his work on nanowire networks. Prof. Boland was appointed Vice President and Dean of Research in 2015. The Dean of Research has responsibility for coordinating and overseeing the University’s research, innovation, technology transfer, and entrepreneurship strategies.
PROF KAREN DAYDean of Science, The University of Melbourne
Professor Day joined the University of Melbourne in 2014 having returned to Melbourne as the newly appointed Dean of Science and a research group leader at the Bio21 Institute and Department of Genetics. A graduate of the University of Melbourne, she completed a PhD at WEHI before taking up a postdoctoral role studying public health problems in Papua New Guinea. This led to a role as Lecturer in molecular epidemiology at both Imperial College(1991‐3) and University of Oxford (1993‐2003) where she held various teaching and administrative posts and was promoted to Reader and Professor for research excellence in malaria population studies. Professor Day moved to New York University School of Medicine in 2004 where she held several senior roles including Professor and Chair of Medical Parasitology, Director of the Institute of Urban and Global Health and Director of the Master’s Program in Global Public Health and continued her malaria research. She is an Emeritus Fellow of Hertford College, Oxford and a member of NYU Society of Fellows. Professor Day is also an expert on higher education, having experience in UK, USA and Australian Universities. She is passionate about science and solving problems in global health.